Other

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ4 2025Feb 13, 2026

How to read this metric

High exercise activity often reflects strong employee confidence in the company's stock performance or the maturity of compensation plans.

Detailed definition

The total number of common shares issued during the period resulting from the exercise of employee stock options. This r...

Peer comparison

Standard disclosure in the statement of changes in equity for companies with stock option plans.

Metric ID: other_stock_issued_during_period_shares_stock_options_exercised

Historical Data

1 periods
 Q4 '25
Value447K

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's share-based compensation arrangement by share-based payment award, options, exercises in period?
Vertex Pharmaceuticals (VRTX) reported share-based compensation arrangement by share-based payment award, options, exercises in period of 447K in Q4 2025.
What does share-based compensation arrangement by share-based payment award, options, exercises in period mean?
Number of shares issued from stock option exercises.